Zhang, YW., Staal, B., Su, Y., Swiatek, P., Zhao, P., Cao, B., Resau, J., Sigler, R., Bronson, R. and Vande Woude, GF. Evidence that MIG-6 is a tumor-suppressor gene. Oncogene (2007) 26, 269–276.
Jiao, Y., Zhao, P., Zhu, J., Grabinski, T., Feng, Z., Guan, X., Skinner, R. S., Gross, M. D., Hay, R., Tachibana, H., and Cao, B. Construction of human naïve Fab library and characterization of anti-Met Fab fragment generated from the library. Molecular Biotechnology 2005; 31:41-54. (Underlined authors contributed equally to the work.)
Ren, Y., Cao, B., Law, S., Xie, Y., Lee, PY., Cheung, L., Chen, Y., Huang, X., Chan, HM., Zhao, P., Luk, J., Vande Woude, G., and Wong J. Hepatocyte Growth Factor Promotes Cancer Cell Migration and Angiogenic Factors Expression: A Prognostic Marker of Human Esophageal Squamous Cell Carcinomas. Clin. Cancer Res. 2005 11: 6190-6197.
Hay, R., Cao, B., Skinner, R. S., Su, Y., Zhao, P., Gustafson, M., Qian, C., Teh, B. T., Knudsen, B., Resau, J., Shen, S., Waters, D., Gross, M. D., and Vande Woude, G. F. Nuclear imaging of Met-expressing human and canine cancer xenografts with radiolabeled monoclonal antibodies (MetSeekTM). Clinical Cancer Research 2005; 11(19 Suppl) 7064s-7069s.
Tan, Min-Han, Carl Morrison, Pengfei Wang, Ximing Yang, Carola J. Haven, Chun Zhang, Maria S. Tretiakova, Eeva Korpi-Hyovalti, John R. Burgess, Khee Chee Soo, Wei-Keat Cheah, Brian Cao, James Resau, Hans Morreau, and Bin Tean Teh. 2004. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma. Clinical Cancer Research 10: 6629–6637.
Zhang, Y.W., Su, Y., Lanning, N., Gustafson, M., Shinomiya, N., Zhao, P., Cao, B., Tsarfaty, G., Wang, L.M., Hay, R., and Vande Woude, G. F. Enhanced growth of human Met-expressing xenografts in a new strain of immunocompromised mice transgenic for human hepatocyte growth factor/scatter factor. Oncogene 2005; 24:101-106.
Hay, Rick V., Brian Cao, R. Scot Skinner, Ling-Mei Wang, Yanli Su, James H. Resau, Beatrice S. Knudsen, Margaret F. Gustafson, Han-Mo Koo, George F. Vande Woude, and Milton D. Gross. 2003. Radioimmunoscintigraphy of human Met-expressing tumor xenografts using Met3, a new monoclonal antibody. Clinical Cancer Research 9(10): 3839S–3844S.
You, Xueke, Hsiao-Man Yu, Leona Cohen-Gould, Brian Cao, Marc Symons, George F. Vande Woude, and Beatrice S. Knudsen. 2003. Regulation of migration of primary prostate epithelial cells by secreted factors from prostate stromal cells. Experimental Cell Research 288(2): 246–256.
Zhao, Ping, Xudong Liang, Jessica Kalbfleisch, Han-Mo Koo, and Brian Cao. 2003. Neutralizing monoclonal antibody against anthrax lethal factor inhibits intoxication in a mouse model. Human Antibodies 12(4): 129–135.
Hay, Rick, Brian Cao, Ilan Tsarfaty, Galia Tsarfaty, James Resau, and George Vande Woude. 2002. Grappling with metastatic risk: bringing molecular imaging of Met expression toward clinical use. Journal of Cellular Biochemistry S39: 184–193.
Hay, Rick V., Brian Cao, R. Scot Skinner, Ling-Mei Wang, Yanli Su, James H. Resau, George F. Vande Woude, and Milton D. Gross. 2002. Radioimmunoscintigraphy of tumors autocrine for human Met and hepatocyte growth factor/scatter factor. Molecular Imaging 1(1): 56–62.
Qian, Chao-Nan, Xiang Guo, Brian Cao, Eric J. Kort, Chong-Chou Lee, Jindong Chen, Ling-Mei Wang, Wei-Yuan Mai, Hua-Qing Min, Ming-Huang Hong, George F. Vande Woude, James H. Resau, and Bin Tean Teh. 2002. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Cancer Research 62(2): 589–596.
Cao, Brian, Yanli Su, Marianne Oskarsson, Ping Zhao, Eric J. Kort, Robert J. Fisher, Ling-Mei Wang, and George F. Vande Woude. 2001. Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proceedings of the National Academy of Sciences U.S.A. 98(13): 7443–7448.
